Release issued 10th October 2002

Patent approvals for SULIDIN® LPS® (Topical Nimesulide Gel) have just been announced in the following countries:

New Zealand Letters Patent No: 510165 Singapore Patent No: 200100879-6 South Africa Patent No: 9817573.0 Eurasian Patent No: 002694 covering: Turkmenistan, Azerbaijan, Moldova, Armenia, Russia, Kazakhstan, Kyrgyzistan, Belorus, Tajikistan

Companies interested in licensing this new technology for these and other territories worldwide should contact Embil Pharmaceutical Co. Ltd. Complete registration dossiers in EU format are available for both 1% and 3% topical gel versions.

(17th November 2004) Sulidin® 1% Nimesulide LPS® gel receives European and US Patents

(7th November 2004) New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004.

(29th December 2003) Two papers on Neo-Penotran® Forte and Neo-Penotran® Forte-L have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004

(6th June 2003) Australian Patent Approval announced for SULIDIN LPS (Topical Nimesulide Gel) formulation.

(9th October 2002) Two New Clinical study reports released for Kortos® HC Cream used in the treatment of benign anorectal diseases.